Bixiye
QP54-22 Update for New to Market Medical Drugs: betibeglogene autotemcel
Taariikhda wax ku ool ah ee barnaamijka: Jun 22, 2022
Natiijooyinka Raadinta
Soo bandhiga 1021 - 1030 ee natiijooyinka 4164
Bixiye
QP39-22 Required Notification of Medicare Organization Determination Request Dismissal and Withdrawal
Taariikhda wax ku ool ah ee barnaamijka: Jun 08, 2022
Bixiye
QP46-22 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective July 28, 2022
Taariikhda wax ku ool ah ee barnaamijka: Jun 08, 2022
Bixiye
QP47-22 Medical Drug Management Update – Alpha-1 Proteinase Inhibitors
Taariikhda wax ku ool ah ee barnaamijka: Jun 08, 2022
Bixiye
QP48-22 MHCP Pharmacy Benefit Exclusion for Korsuva™ and Leqvio®
Taariikhda wax ku ool ah ee barnaamijka: Jun 08, 2022
Bixiye
QP49-22 Commercial Pharmacy Benefit Exclusion for Carvykti™, Korsuva™, and Leqvio®
Taariikhda wax ku ool ah ee barnaamijka: Jun 08, 2022
Bixiye
QP50-22 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 1, 2022
Taariikhda wax ku ool ah ee barnaamijka: Jun 08, 2022
Bixiye
QP51-22 Blue Cross Preferred Genetic Laboratory Program
Taariikhda wax ku ool ah ee barnaamijka: Jun 08, 2022
Bixiye
QP53-22 New Operational Trends Dashboard
Taariikhda wax ku ool ah ee barnaamijka: Jun 08, 2022